[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351806-105":59,"doc-detail-351806-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chemotherapy-induces-an-il1-dependent-neutrophil-recruitment-and-activation-that-promote-chemoresistance-in-metastatic-ovarian-cancer","Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer","","High-grade serous carcinoma of the ovary develops chemoresistance via tumor-extrinsic and tumor-intrinsic mechanisms, yet how chemotherapy reshapes the intraperitoneal immune microenvironment to sustain ongoing treatment failure remains unclear. Paired bulk transcriptomics and single-cell RNA sequencing were used to map chemotherapy-driven extrinsic factors and cellular sources, focusing on the IL1β–IL1R1 axis. Functional testing in murine metastatic models, neutrophil/NET depletion, and analyses of patient specimens show IL1β-dependent neutrophil recruitment and NET formation that impair chemosensitivity and worsen tumor control.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemotherapy-induces-an-il1-dependent-neutrophil-recruitment-and-activation-that-promote-chemoresistance-in-metastatic-ovarian-cancer/351806/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemotherapy-induces-an-il1-dependent-neutrophil-recruitment-and-activation-that-promote-chemoresistance-in-metastatic-ovarian-cancer/351806.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What pathway mediates the chemotherapy-driven immune changes in metastatic ovarian cancer?","Question",{"text":112,"@type":113},"The study identifies the IL1β–IL1R1 axis as central, with myeloid cells as the primary source of IL1β after chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do neutrophils and NETs influence chemosensitivity according to the study?",{"text":117,"@type":113},"Chemotherapy increases neutrophils and NET formation in omental tumors, and NETs reduce cancer cell chemosensitivity; neutrophil depletion shifts toward a more chemosensitive phenotype.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence links IL1β signaling to improved tumor control when IL1β is disrupted?",{"text":121,"@type":113},"In IL1β-deficient models, there is reduced neutrophil accumulation, a shift toward an effector-like CD8+ T-cell state, and improved tumor control.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351806,1790618182,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Open access Original research  \nChemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer  \nTaito Miyamoto,1,2 Yujie Ye,1 Marlaine M Soliman,3 Bryan S Manning,1,4 Brennah Murphy,1 Linna Zhu,5 Chunlei Shao,1 Gauri Mirji,1 Moeko Minakuchi,1 Kohei Hamada,2 Rin Mizuno,2 Mana Taki,2 Koji Yamanoi,2 Ryusuke Murakami,2 Masaki Mandai,2 Ying Ye,1 Jayamanna Wickramasinghe,1 Yulia Nefedova,1 Rahul Shinde  ,1 Andrew Kossenkov,1 Nan Zhang  1,3  \nTo cite: Miyamoto T,  \nYe Y, Soliman MM, et al. Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer. Journal for ImmunoTherapy of Cancer 2026;14:e014253 . doi:10.1136/jitc-2025-014253  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2025-014253](jitc-2025-014253)) .  \nTM and YY contributed equally. Accepted 14 May 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Nan Zhang; [nzhang@wistar.org](nzhang@wistar.org)  \nDr Taito Miyamoto;  \n[miyamototaito3@gmail.com](miyamototaito3@gmail.com)  \nABSTRACT  \nBackground High-grade serous carcinoma (HGSC) of the ovary acquires chemoresistance through diverse cancer cell-intrinsic and cell-extrinsic mechanisms, culminating in treatment-refractory intraperitoneal metastasis. Previous work suggests that chemotherapy induces immunological changes in the tumor microenvironment (TME). However, experimental evidence for how such chemotherapyinduced TME remodeling modulates the response to ongoing chemotherapy remains poorly documented in HGSC.  \nMethods We analyzed paired pre-chemotherapy and post-chemotherapy HGSC bulk transcriptomic and singlecell RNA sequencing (scRNA-seq) datasets to identify chemotherapy-induced tumor-extrinsic factors and their cellular sources in the TME. To test causality, we used chemoresistant, homologous recombination-proficient murine metastatic HGSC models with deficiencies in the interleukin 1 beta (IL1β) pathway (IL1β–interleukin 1 receptor type 1 (IL1R1) axis) . Flow cytometry and scRNAseq of omental tumors were used to define cellular interactions. Contributions of neutrophils and neutrophil extracellular traps (NETs) were assessed by antibodymediated depletion and immunofluorescence. Direct effects of IL1β and NETs on cancer cell chemosensitivity were tested in vitro. Finally, paired pre-chemotherapy and post-chemotherapy omental HGSC specimens from patients were analyzed for neutrophil infiltration and NET formation.  \nResults In HGSC datasets, post-chemotherapy tumors exhibited increased IL1β expression with myeloid cells identified as the primary source. In chemoresistant murine models, chemotherapy increased neutrophils and NETsin omentum tumors in wild-type mice. These increases were abrogated in IL1β-deficient mice, which showed a shift toward an effector-like CD8+ T-cell state and improved tumor control. Neutrophil depletion in wildtype mice recapitulated the chemosensitive phenotype of IL1β-deficient mice. In vitro, IL1β did not alter cancer cell-intrinsic chemosensitivity, whereas NETs reduced the chemosensitivity of cancer cells. Furthermore, scRNA-seq and flow cytometry revealed that IL1R1 was predominantly  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Ovarian cancer acquires chemoresistance through diverse cancer cell-intrinsic and cell-extrinsic mechanisms. Although chemotherapy-induced remodeling of the intraperitoneal immune tumor microenvironment in ovarian cancer has been reported, experimental evidence demonstrating how a specific tumor-extrinsic pathway, with defined cellular players, influences chemosensitivity remains limited.\u003Cbr>W","cbCaibu6VfyO47VF","https://ap.wps.com/l/cbCaibu6VfyO47VF","pdf",5791300,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Known Findings and Study Additions\n## What is already known on this topic\n## What this study adds\n## How this study might affect research, practice or policy","[{\"question\":\"What pathway mediates the chemotherapy-driven immune changes in metastatic ovarian cancer?\",\"answer\":\"The study identifies the IL1β–IL1R1 axis as central, with myeloid cells as the primary source of IL1β after chemotherapy.\"},{\"question\":\"How do neutrophils and NETs influence chemosensitivity according to the study?\",\"answer\":\"Chemotherapy increases neutrophils and NET formation in omental tumors, and NETs reduce cancer cell chemosensitivity; neutrophil depletion shifts toward a more chemosensitive phenotype.\"},{\"question\":\"What evidence links IL1β signaling to improved tumor control when IL1β is disrupted?\",\"answer\":\"In IL1β-deficient models, there is reduced neutrophil accumulation, a shift toward an effector-like CD8+ T-cell state, and improved tumor control.\"}]","Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer | PDF",1790095992,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da6621a37cae480499ca649448b468cf.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32eec9d1a7bfe00f35eee95299c9500a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f65280c46c81e045483b228174ffeaf0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44b74c7cd6a76b1b93b6136cf5724775.webp",980,1306]